GDF2 and pulmonary arterial hypertension: Our findings pointing to a molecular link between BMP9 signaling and RAD51 open a new therapeutic avenue aimed at rescuing the DNA repair enzyme and preventing DNA damage as a way to halt or delay the development of vascular remodeling in pulmonary arterial hypertension from an early stage.